News Archive

A study of proteins in plasma taken from patients in the IPF-PRO registry found that patients with IPF have a distinct circulating set of proteins and that select proteins correlate well with clini

With machine learning on the rise, DCRI’s Eric Peterson, MD, MPH, takes a retrospective look at prior efforts to implement risk prediction models and what lessons can be drawn from the past for cur

The exploratory study of patients with atrial fibrillation and on hemodialysis evaluated rates of bleeding when randomized to apixaban versus warfarin.

Fifty-four researchers from Duke, including nine from the DCRI, were recognized for their high citation rates.

Data monitoring committees could be provided more and better data in order to fulfill its role of protecting trial participants.

A new analysis of a DCRI study revealed that younger patients and older patients may need to undergo different types of testing for coronary artery disease in order to more accurately predict risk.

Patients who experienced Type 2 myocardial infarction were older and more likely to have comorbidities and risk factors than those who experienced Type 1.

The DCRI served as the statistical and data coordinating center for ISCHEMIA, a late-breaking clinical trial that indicated invasive heart procedures may not reduce the chance of experiencing a maj

By enrolling 8,500 high-risk patients with a recent atherosclerotic cardiovascular disease event, cvMOBIUS will be the first large-scale registry to evaluate real-world lipid management and the effectiveness of PCSK9 inhibitors.

No single stakeholder can successfully address the challenges in clinical research.